Loading…
ICON Public Limited Company is projected to rise to $216.91 by 2027, a +31% move from its current price of $165.53. ICLR is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/31/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 1 | $161.07 | $165.61 | $170.29 | +0.05% |
| Aug 2 | $159.30 | $165.70 | $172.35 | +0.10% |
| Aug 3 | $157.98 | $165.78 | $173.97 | +0.15% |
| Aug 4 | $156.89 | $165.87 | $175.36 | +0.20% |
| Aug 5 | $155.94 | $165.95 | $176.61 | +0.26% |
| Aug 6 | $155.09 | $166.04 | $177.75 | +0.31% |
| Aug 7 | $154.33 | $166.12 | $178.82 | +0.36% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $154.33 | $166.12 | $178.82 | +0.36% |
| Week 2 | $150.22 | $166.71 | $185.02 | +0.72% |
| Week 3 | $147.27 | $167.31 | $190.08 | +1.08% |
| Week 4 | $144.91 | $167.91 | $194.56 | +1.44% |
| Week 5 | $142.92 | $168.51 | $198.68 | +1.80% |
| Week 6 | $141.19 | $169.11 | $202.54 | +2.16% |
| Week 7 | $139.66 | $169.71 | $206.23 | +2.53% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
ICON Public Limited Company is a clinical research organization (CRO) that provides outsourced development and commercialization services in Ireland, Europe, the United States, and internationally. The company specializes in strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also offers clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, contract staffing, data solutions, and laboratory services; and commercial services comprising clinical development strategy, planning, and trial design, full study execution, and post-market commercialization.
ICON also provides testing services including bioanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. ICON was incorporated in 1989 and is headquartered in Dublin, Ireland.
ICON Public Limited Company, symbol ICLR, is trading at $168.78 with a market capitalization of $13.02B, and it ranks 732 by market cap. The current price sits near the near-term technical baseline, with forecasts suggesting a bullish longer-term price path. The year-by-year forecast shows a progression from a neutral 2026 as a starting point to sustained bullish momentum through 2050, with significant upside potential reflected in the max prices and ROIs listed for later years.
A major floor 39.6% below — a decisive break under it would weaken the trend.
The nearest floor, 15.0% below — buyers have tended to step in here.
The nearest ceiling, 8.9% above — a clean break opens room to run.
A major ceiling 21.8% above — clearing it would confirm fresh momentum.
Key ICLR support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ICLR market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $171.70 | Sell | $171.25 | Sell |
| MA 10 | $169.89 | Sell | $170.53 | Sell |
| MA 20 | $169.49 | Sell | $167.80 | Sell |
| MA 50 | $153.96 | Buy | $155.97 | Buy |
| MA 100 | $131.91 | Buy | $147.08 | Buy |
| MA 200 | $148.37 | Buy | $149.41 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 50.44 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -91.16 | Neutral |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.90 | Sell |
| ROC (12) | -1.45 | Sell |
| Bollinger %B (20,2) | 0.25 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | 0.51 | Buy |
| Awesome (5,34) | 8.15 | Buy |
| Ultimate (7,14,28) | 49.89 | Neutral |
| Momentum (10) | -4.47 | Sell |
| Aroon Osc (25) | 92.00 | Buy |
| Hull MA (9) | 176.02 | Sell |
| ADX (14) | 24.48 | Buy |
| ATR (14) | 4.01 | Info |
The 30-day technical picture is bullish with RSI14 at 60. SMA50 is $149.46 and SMA200 is $148.64, supporting a positive near-term bias. Near-term support is at $140.73 and resistance at $175.05, with the 30-day trading range from $146.62 to $194.28. Annualized volatility is high at 40%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $80.08 | $165.53 | $218.54 | 0% | Neutral | |
| $172.66 | $216.91 | $288.29 | +31% | Bullish | |
| $224.37 | $290.11 | $400.59 | +75% | Bullish | |
| $265.05 | $350.97 | $499.23 | +112% | Bullish | |
| $280.34 | $379.10 | $552.85 | +129% | Bullish | |
| $307.11 | $423.31 | $630.87 | +156% | Bullish | |
| $333.06 | $467.32 | $710.11 | +182% | Bullish | |
| $379.96 | $542.10 | $838.36 | +227% | Bullish | |
| $466.72 | $676.52 | $1,063.29 | +309% | Bullish | |
| $510.94 | $751.94 | $1,199.68 | +354% | Bullish | |
| $794.92 | $1,253.26 | $2,129.03 | +657% | Bullish | |
| $1,339.28 | $2,377.70 | $4,425.16 | +13.4x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $80.08 | $165.53 | $193.05 | +0.00% |
| August 2026 | $141.88 | $166.59 | $200.21 | +0.64% |
| September 2026 | $146.43 | $173.40 | $211.26 | +4.09% |
| October 2026 | $148.23 | $176.74 | $217.65 | +1.92% |
| November 2026 | $144.37 | $173.11 | $215.04 | -2.05% |
| December 2026 | $144.82 | $174.54 | $218.54 | +0.83% |
Click any year to see its month-by-month ICLR forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, ICLR is projected to trade between $80.08 and $218.54, averaging $165.53 — a potential gain of 0% from today's $165.53. A consolidation phase looks the most probable path here.
ICON Public Limited Company's 2027 outlook centres on $216.91, within a $172.66 to $288.29 range. That is up +31% on the projected 2026 average. That marks a +31% change versus current levels. Momentum favours further upside here.
By 2028, ICLR could reach as high as $400.59, with a base case around $290.11 and support toward $224.37 — roughly +75% from $165.53. Buyers look set to stay in control over this stretch.
Expect ICLR to range from $265.05 to $499.23 through 2029. The $350.97 average target implies a +112% move from current prices. That is up +21% on the projected 2028 average. Momentum favours further upside here.
The ICLR price prediction for 2030 points to an average of $379.10 (low $280.34, high $552.85) — a potential gain of +129% on today's $165.53. Buyers look set to stay in control over this stretch.
In 2031, ICLR is projected to trade between $307.11 and $630.87, averaging $423.31 — a potential gain of +156% from today's $165.53. That is up +12% on the projected 2030 average. Momentum favours further upside here.
ICON Public Limited Company's 2032 outlook centres on $467.32, within a $333.06 to $710.11 range. That is up +10% on the projected 2031 average. That marks a +182% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, ICLR could reach as high as $838.36, with a base case around $542.10 and support toward $379.96 — roughly +227% from $165.53. Momentum favours further upside here.
Expect ICLR to range from $466.72 to $1,063.29 through 2034. The $676.52 average target implies a +309% move from current prices. That is up +25% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The ICLR price prediction for 2035 points to an average of $751.94 (low $510.94, high $1,199.68) — a potential gain of +354% on today's $165.53. Momentum favours further upside here.
In 2040, ICLR is projected to trade between $794.92 and $2,129.03, averaging $1,253.26 — a potential gain of +657% from today's $165.53. That is up +67% on the projected 2035 average. Buyers look set to stay in control over this stretch.
ICON Public Limited Company's 2050 outlook centres on $2,377.70, within a $1,339.28 to $4,425.16 range. That is up +90% on the projected 2040 average. That marks a +13.4x change versus current levels. Momentum favours further upside here.
Investing $1,000 in ICLR today (≈ 6.041201 ICLR) could be worth
$14,364.18
+$13,364.18 (+1336%) by 2050 · US Dollar
Based on the average projected ICLR price of $2,377.7 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ICLRwould be worth at today's price.
$1,000 invested in ICLR on Jul 30, 2025 (≈ 5.509642 ICLR) would be worth
$912.01
-$87.99 (-8.8%) today · 0.91× · US Dollar
Based on a ICLR entry price of $181.5 vs. today's $165.53.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $170.32 | $971.88 | -2.8% |
| 1 month ago | $173.71 | $952.91 | -4.7% |
| 3 months ago | $112.85 | $1,466.81 | +46.7% |
| 6 months ago | $180.25 | $918.34 | -8.2% |
| 1 year ago | $181.5 | $912.01 | -8.8% |
| All time (5.0y) ago | $246.55 | $671.39 | -32.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ICLR forecast.
Our base-case forecast reaches $330.00 around 2029.
Implied market cap at $330.00: $25.46B
The multi-year forecast shows a strong bullish trajectory. In 2026 the avg price is $168.78 with a min of $80.08 and a max of $222.13, and the ROI is 0. By 2030 the avg price rises to $392.46 with a max of $545.12 and ROI of 132.5%.
By 2040 the avg price is $1,324.72 with a max of $2,084.20 and ROI of 684.9%. By 2050 the avg price is $2,608.14 with a max of $4,428.02 and ROI of 1445.3%. The forecast sentiment remains BULLISH across the later years (2027 through 2050).
These figures are estimates and not guaranteed; actual results may differ.
Tap a question to reveal the answer.
The 2030 forecast shows an avg price of $392.46, with a min of $302.12 and a max of $545.12; ROI is 132.5% and sentiment is BULLISH.
Forecasts indicate a bullish trajectory from 2027 onward, with rising averages and ROIs: 2027 avg $224.86 (ROI 33.2%), 2028 avg $294.26 (74.3%), 2029 avg $356.74 (111.4%), 2030 avg $392.46 (132.5%), 2040 avg $1,324.72 (684.9%), 2050 avg $2,608.14 (1445.3%). These are estimates and not guaranteed.
Yes. The forecast max reaches $2,084.20 by 2040 and $4,428.02 by 2050, indicating potential to exceed $1,000 in the long term; these are estimates and not guaranteed.
Current price is $168.78 and market cap is $13.02B.
Near-term technicals show bullish sentiment with RSI 60, SMA50 at $149.46, SMA200 at $148.64. Support is at $140.73, resistance at $175.05, and the 30-day range spans $146.62 to $194.28.
ICON Public Limited Company Community Discussion
0Share your ICON Public Limited Company price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.